Particle.news

Download on the App Store

FDA Commissioner Affirms No Immediate Plans to Restrict Abortion Pill Access

Marty Makary states mifepristone access will remain unchanged unless future safety data signals an issue.

Former Republican presidential candidate and former U.S. Vice President Mike Pence is seen delivering remarks at the Faith and Freedom Road to Majority conference at the Washington Hilton on June 23, 2023, in Washington, D.C. (Photo by Drew Angerer/Getty Images)
Image

Overview

  • FDA Commissioner Marty Makary confirmed there are no current plans to impose new restrictions on mifepristone access, despite ongoing pressure from anti-abortion groups.
  • Makary emphasized that any future regulatory changes would depend on new safety data, reiterating the agency's reliance on evidence-based decision-making.
  • Mifepristone, approved in 2000 and paired with misoprostol, is used in the majority of U.S. medication abortions and has been extensively studied for safety and efficacy.
  • The Supreme Court previously dismissed a legal challenge by anti-abortion groups seeking to restrict mifepristone, citing lack of standing.
  • Makary's comments mark a firmer stance compared to his Senate confirmation hearing, where he pledged to review data but did not commit to specific actions.